Emmaus Life Sciences,'s Revenue in the fiscal year 2018 $ 15.08 millions
Emmaus Life Sciences,'s Revenue in the fiscal year 2017 $ 0.51 millions
Emmaus Life Sciences,'s Revenue in the fiscal year 2016 $ 0.46 millions
Emmaus Life Sciences,'s Revenue in the fiscal year 2015 $ 0.59 millions
Emmaus Life Sciences,'s Revenue in the fiscal year 2014 $ 0.50 millions
EMMA Revenue first quarter 2019 Y/Y Growth Comment
Emmaus Life Sciences, Inc. reported Revenue surge of 580.38% year on year in the first quarter 2019, to $ 5.31 millions, this is lower than Emmaus Life Sciences, Inc.'s recent average Revenue surge of 874.55%.
According to the results reported in the first quarter 2019, Emmaus Life Sciences, Inc. achieved the best Revenue growth in Blank Checks industry. While Emmaus Life Sciences, Inc.' s Revenue doubling of 580.38% ranks overall at the positon no. 74 in the first quarter 2019.
Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019
Emmaus Life Sciences,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
431.45 %
62.48 %
-64.2 %
(Mar 31 2018)
EMMA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Emmaus Life Sciences, Inc. disclosed fall in Revenue from the fourth quarter by -22.41% to $ 5.31 millions, from $ 6.84 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2019 Revenue, this plainly could not be substantial to rescue Blank Checks's company achievement, Most analysts pointed out.
Within Blank Checks industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Emmaus Life Sciences,'s Revenue growth quarter on quarter, overall rank is 3289.
In the I. Quarter 2019 Emmaus Life Sciences, Inc. disclosed fall in Revenue from the fourth quarter by -22.41% to $ 5.31 millions, from $ 6.84 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2019 Revenue, this plainly could not be substantial to rescue Blank Checks's company achievement, Most analysts pointed out.
Within Blank Checks industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Emmaus Life Sciences,'s Revenue growth quarter on quarter, overall rank is 3289.
Emmaus Life Sciences,'s 12 Months Revenue Growth Year on Year
Assuming the Emmaus Life Sciences,'s fiscal year would have ended in Mar 31 2019, Emmaus Life Sciences, would have reprted above average annual Revenue surge of 1551.04% year on year, of $ 20 millions. This marks a slow-down of the companys growth trends and from the 2836.39% surge in Dec 31 2018.
Within the Financial sector 33 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 19 to 20.
Assuming the Emmaus Life Sciences,'s fiscal year would have ended in Mar 31 2019, Emmaus Life Sciences, would have reprted above average annual Revenue surge of 1551.04% year on year, of $ 20 millions. This marks a slow-down of the companys growth trends and from the 2836.39% surge in Dec 31 2018.
Within the Financial sector 33 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 19 to 20.
About Emmaus Life Sciences, Revenue Growth Rates (EMMA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
947.90%